Dr. Phillip Pasquale Santoiemma, MD

Dr. Santoiemma practices at Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare.

Dr. Santoiemma's NPI, 1013301126, was assigned on March 26, 2015. Dr. Santoiemma graduated from Perelman School of Med at the University of Pennsylvania in 2015. Dr. Santoiemma holds Illinois license 036144097.

Dr. Santoiemma's primary practice is Northwestern Memorial Hospital, at 251 E Huron St, Chicago, IL 60611 in Cook County. The practice phone is (312) 926-2000.

Dr. Santoiemma's primary practice is Northwestern Memorial Hospital in Chicago, Illinois, part of Northwestern Memorial HealthCare. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Santoiemma to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Santoiemma practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Santoiemma's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Santoiemma is licensed in Illinois.

CMS data shows 395 Medicare services from Dr. Santoiemma across 6 procedure codes in 2024, for 224 Medicare patients. Medicare paid $37,549 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 224 Medicare patients who saw Dr. Santoiemma in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 3.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Santoiemma's median patient age at 70, with 42% women.

In 2024, Dr. Santoiemma wrote 224 Medicare Part D claims for 60 patients. 75% of them were for generic drugs. CMS names the drug for 116 of them, across 4 drugs with 11 or more claims each, at $240,226 in total drug cost. In 2023, CMS named 130 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Santoiemma for performance year 2024, reported through an alternative payment model (APM). Dr. Santoiemma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Santoiemma as offering telehealth.

Dmand AI links 12 papers to Dr. Santoiemma, published from 2017 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Bacterial Infections, Anti-Bacterial Agents and Immunocompromised Host. Dr. Santoiemma has published most often in PLoS One. Dr. Santoiemma's most frequent co-authors are Michael Peter Angarone, DO, Kendall David Kling, MD and Karen M. Krueger, MD.

CMS Open Payments shows 5 general payments to Dr. Santoiemma from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 91% of the total. ViiV Healthcare Company paid the most, $198.

Dr. Santoiemma graduated from Perelman School of Med at the University of Pennsylvania in 2015.